Detalles de la búsqueda
1.
Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial.
Eur J Haematol
; 100(5): 465-474, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427355
2.
In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification.
Bioorg Med Chem
; 24(21): 5076-5087, 2016 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27600403
3.
Prognostic value of thymidine kinase activity in patients with chronic lymphocytic leukemia.
Postepy Hig Med Dosw (Online)
; 70(0): 1321-1330, 2016 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28100842
4.
Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.
Eur J Haematol
; 92(2): 91-101, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24138550
5.
Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro.
Postepy Hig Med Dosw (Online)
; 68: 1433-43, 2014 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25531707
6.
Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.
Eur J Haematol
; 91(1): 1-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23521128
7.
R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis.
J Cell Biochem
; 109(1): 217-35, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19911397
8.
Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclindependent kinase inhibitors.
Mol Med Rep
; 19(5): 3593-3603, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30864706
9.
Bendamustine alone or with rituximab modifies expression of apoptosis-regulating genes and proteins of CLL cells, depending on IGVH mutational status.
Leuk Lymphoma
; 60(6): 1409-1419, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30187811
10.
Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application.
Mini Rev Med Chem
; 7(9): 976-83, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17897085
11.
Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma.
Leuk Lymphoma
; 48(6): 1092-101, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17577772
12.
Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development.
Oncol Lett
; 13(4): 2079-2084, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454364
13.
Health-related quality of life and patient-reported outcomes of ofatumumab plus fludarabine and cyclophosphamide versus fludarabine and cyclophosphamide in the COMPLEMENT 2 trial of patients with relapsed CLL.
Leuk Lymphoma
; 58(7): 1598-1606, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27830957
14.
Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial.
Leuk Lymphoma
; 58(5): 1084-1093, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27731748
15.
In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone.
Oncol Rep
; 16(6): 1389-95, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17089066
16.
Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia.
Semin Oncol
; 43(2): 280-90, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27040707
17.
The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
Haematologica
; 90(7): 994-6, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15996945
18.
Changes in leukemic cell nuclei revealed by differential scanning calorimetry.
Leuk Lymphoma
; 46(1): 121-8, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15621789
19.
Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
Eur Cytokine Netw
; 16(1): 41-6, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15809205
20.
Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia.
Int J Oncol
; 46(3): 1259-67, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25572009